With the NBA ’s return on Tuesday evening, Shaquille O'Neal, Charles Barkley and TNT’s "Inside the NBA" were back to cover ...

Currently, financial markets are experiencing a mix of optimism and caution as investors react to changing economic ...

When you're taking GLP-1 medications for weight loss, it's easy for nutrition to get overlooked because while semaglutide ...

Amid ongoing legal battles over coveted GLP-1 therapies, a drug vendor in Washington state is accused of running an ...

SURVEY SAYS: Just 18% of the health-care plans sponsored by employers with 200 workers or more cover such drugs, according to ...

The Center for Human Nutrition at the U of A is conducting a research study to learn more about the effects of protein on body composition and wellbeing in people getting ready to take weight loss ...

A recent study found significant reductions in opioid overdose and alcohol misuse among people taking GLP-1 drugs like ...

Clinical and other trials for GLP-1 therapies have found an association between these drugs and diabetic retinopathy ...

Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the US Food and Drug Administration revisits its Oct. 2 decision to remove the medicine from a ...

In a reversal, the FDA is reconsidering its decision to end the shortage status of tirzepatide, after a recent lawsuit and intense public pressure, The Washington Post reported Oct. 21.

Pharmaceutical powerhouse Eli Lilly (NYSE: LLY) is having a terrific 2024. Shares have gained 58% so far this year, handily ...

To make $1 million in the stock market, you don't need to invest a fortune. But you'll definitely want to take the time to ...